CoreAge Rx vs PrideRx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and PrideRx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 63 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make PrideRx a bad call — it's best for readers seeking named branded prescriptions who can compare the continuing care fee with the separate medication charge. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | PrideRx |
|---|---|---|
| Brief Score | 94/100 (A) | 63/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Wegovy Pill: care + separate medication Care $25 first month, then $99/month. Medication advertised from $149/month through NovoCare; comparison dated September 2026 and prices may change. Confirm selected dose/supply and pharmacy price. Membership cancellation does not establish cancellation of a separate manufacturer-pharmacy order. Full price detailsNamed Wegovy Pill program offered; complete selected-dose quote unknown; care $25 first month then $99/month plus medication advertised from $149/month through NovoCare; comparison dated September 2026 |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Zepbound: care + separate medication Care $25 first month, then $99/month. Medication advertised from $299/month at 2.5 mg through LillyDirect; higher doses priced separately. KwikPen described as four weekly doses. Confirm actual pharmacy payment, supplied period and separate prescription cancellation/refund terms. Full price detailsNamed Zepbound program offered; complete selected-dose quote unknown; care $25 first month then $99/month plus medication advertised from $299/month at 2.5 mg through LillyDirect; higher doses listed separately |
| Coverage | US only; restrictions by state, confirmed at intake | All 50 states advertised through MD Integrations, subject to clinical appropriateness, state law and pharmacy availability |
| Brand-name access | Not confirmed | Current pages advertise Wegovy Pill, Zepbound and Foundayo with separate manufacturer-channel medication billing; eligibility and dose determine the actual prescription. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
PrideRx: Care costs $25 first month, then $99 monthly; medication is separate. Wegovy Pill from $149 and Zepbound 2.5 mg from $299 require a current pharmacy quote and separate cancellation terms.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.